TABLE 4.

Large Clinical Trials and Cohort Studies Using 123I-MIBG for Heart Failure Prognostication and PD or DLB Diagnosis

IndicationStudyType of studyYearStudy patientsDelayed timeDelayed HMR threshold or mean ± SDWR threshold or mean ± SD
Heart failureSeo et al.Single center20221483.3 h1.9
Nakata et al.Multicenter201313223–4 h1.6843%
Doi et al.Single center20124684 h1.57 and 1.50 ± 0.3641.3% ± 9.8%
Jacobson et al.Multicenter20109613 h 50 min1.6 and 1.39 ± 0.1841.8% ± 17.3%
Nakata et al.Single center19984143–4 h1.74 and 1.56 ± 0.36
PD or DLBOdagiri et al.Single center2016543 h1.59 ± 0.34 for PD/1.31 ± 0.21 for DLB
Oka et al.Single center20111103–4 h1.58 ± 0.43
Kashihara et al.Single center20061884 h1.37 ± 0.27 for PD/1.47 ± 0.37 for DLB
Nagayama et al.Single center20053914 h1.38 ± 0.29 for PD/1.17 ± 0.06 for DLB
  • Variety of delayed times were used, with 4 h being most common. Various thresholds and mean values for delayed HMR and WR were used or discovered. 1.6 delayed HMR threshold used in ADMIRE-HF trial does tend to fit many trial thresholds and mean values (32,46,48,5560).